FDA Deputy Commissioner Pendergast to become Elan Exec VP-Government Affairs effective Jan. 5.
This article was originally published in The Gray Sheet
Executive Summary
FDA DEPUTY COMMISSIONER PENDERGAST TO BECOME ELAN EXEC VP-GOVERNMENT AFFAIRS following her resignation from the agency effective Jan. 2. Mary Pendergast will be based in Washington, D.C. in the newly created position. Elan, based in Athlone, Ireland, is primarily involved in drug delivery work, and its attempts to develop new formulations have occasionally raised regulatory issues at FDA. For example, Pfizer sought to prevent approval of Elan's sustained-release nifedipine formulation Nifelan via an FDA citizen's petition.